SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending after announcing record-high vehicle deliveries for December and the fourth quarter, significantly surpassing previous figures and nearing one million cumulative vehicles. This strong performance, further supported by extended EV subsidies in China, is driving considerable community discussion and optimism about the company's path to profitability and its competitive standing in the electric vehicle market.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP Crypto is trending after a recent price surge ignited a polarized community discussion. Supporters emphasize its real-world utility through Flexa's merchant network and anticipate significant growth with pending regulatory clarity and strategic partnerships. However, many investors express deep frustration, warning of sustained manipulation and a history of pump-and-dump cycles despite its technological foundations.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is a hot topic following its announcement of a strategic manufacturing partnership designed to scale production of its fingerprinting drug screening reader and reduce costs. The market is heavily divided, with many anticipating explosive gains due to the stock's low float, while others express significant concern over recent share dilution from a private placement with warrants. This has created extremely volatile trading activity, as bullish momentum traders clash with short-sellers over the stock's immediate future.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is currently trending amidst significant investor confusion and frustration surrounding a recent dividend event and persistent tracking discrepancies with its underlying asset, SMCI. The community is actively questioning the ETF's unusual behavior, with some alleging it's a "scam" or facing an imminent reverse split, while others view the current downturn as a potential buying opportunity despite concerns about leveraged product decay.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is currently a hot topic, with community discussion centering on the ongoing delay and mixed initial data for its inhaled cystic fibrosis therapy, ARCT-032, which showed some mucus plug reduction but not significant lung function improvements. Investors are closely monitoring an active trade secret lawsuit against AbbVie, generating widespread hope for a substantial settlement or potential acquisition. Many believe the company's advanced mRNA platform and solid cash runway make the stock deeply undervalued amidst significant short interest.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc is a key topic as it actively positions itself for the substantial Rural Health Transformation Program, aiming to modernize rural healthcare with its virtual care network and AI-driven solutions. Investors are vocal, with some passionately highlighting the company's global leadership and significant undervaluation, expecting a major turnaround, while others voice deep frustration over past stock performance and current management's perceived shortcomings. Recent discussions also revolve around strategic partnerships, such as the TytoCare integration for at-home care, as potential catalysts.

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

Widespread speculation about a potential SpaceX initial public offering is driving significant market conversation and creating considerable buzz within the aerospace sector. This anticipation is fueling active community discussion around related companies positioned as 'SpaceX IPO plays' or partners, notably highlighting firms involved in upcoming Falcon 9 missions. However, alongside the excitement, some investors are raising cautionary flags about speculative mentions and the legitimacy of certain 'SPACEX CRYPTO' references.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending amid intense community discussion following recent developments, including a partial summary judgment in its ongoing litigation and strategic changes to its executive team, which are fueling heightened speculation around a potential acquisition. Investors are closely monitoring progress for its rare disease therapy, MIPLYFFA, toward European market access and a patent term extension, while broadly criticizing management for perceived undervaluation and executive compensation. Despite these concerns, many maintain a bullish outlook, citing the company's significant cash reserves and pipeline assets as indicators of untapped value.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is gaining attention for its expanding anticoagulation pipeline, highlighted by recent acquisitions and significant progress on its lead candidate, tecarfarin, including manufacturing readiness and a collaboration with Abbott. This "quiet expansion" is sparking community interest, with many anticipating a breakout given its low float and regulatory designations. However, skepticism persists among some regarding the company's financial stability and potential dilution.

Polestar Automotive Holding UK Plc is the Swedish electric performance car brand that engages in the research, development, marketing, commercialization, and sales of battery electric vehicles and related technology solutions. It offers Polestar 2 (PS2), a premium fast-back sedan, the Polestar 3 (PS3), a luxury aero sport-utility vehicle, the Polestar 4 (PS4), a premium sport utility vehicle, the Polestar 5 (PS5), a luxury sport grand-touring sedan, and the Polestar 6 (PS6), a luxury roadster. The company was founded on September 15, 2021 and is headquartered in Gothenburg, Sweden.

Polestar Automotive Holding UK PLC - ADR Class A

Polestar is a hot topic following a substantial $600 million financing boost and the looming 1-for-30 reverse stock split, which has sparked intense debate among investors. While many are optimistic about strong Q4 delivery numbers for the Polestar 4 and new Google Gemini AI integration, community sentiment remains sharply divided on whether operational improvements can finally overcome persistent skepticism about the stock's performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LUNR February 2026 Options Begin Trading

Investors in Intuitive Machines Inc (Symbol: LUNR) saw new options begin trading today, for the February 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the...

In this photo illustration, the Sidus Space logo is seen displayed on a smartphone screen.

Sidus Space’s Sudden Liftoff: How A Tiny Defense Win Sparked A Massive Rally

Pentagon backing for more AI-powered data solutions and a part of the Golden Dome contract has helped Sidus Space see a surge.

Equity

What's Going On With Intuitive Machines (LUNR) Stock Monday?

Intuitive Machines shares are trading higher Monday. Clear Street maintained a Buy rating and raised the price target to $25.read more...

Intuitive Machines (NASDAQ:LUNR) Trading 5.1% Higher - Here's Why

Intuitive Machines (NASDAQ:LUNR) Trading 5.1% Higher - Time to Buy...

<ul class="summary-bullets"><li>The&nbsp;Lanteris&nbsp;acquisition is anticipated to add revenue and boost adjusted earnings before interest, taxes, depreciation, and amortization once complete.</li><li>Clear Street increased its price target on the stock to $25 from $17.</li><li>Intuitive Machines has received a boost from the Trump administration’s recent&nbsp;space policy.</li></ul>Clear Street has raised its price target on Intuitive Machines, Inc. (LUNR) to $25 from $17 and retained a ‘Buy’ rating, citing the pending acquisition of Lanteris as a major catalyst for future growth.&nbsp;&nbsp;The new price target implies a potential upside of 56% from the stock’s current price of about $16.In November, Intuitive Machines agreed to acquire&nbsp;Lanteris Space Systems, formerly known as Maxar Space Systems, from private equity firm Advent International.<h2 class="st-heading-2">Strategic Expansion</h2>Clear Street highlighted that Intuitive Machines’ planned purchase of Lanteris Space Systems, expected to close by the second quarter of 2026, is now reflected in the firm’s forecasts, according to TheFly.&nbsp;The acquisition is expected to add revenue and boost adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) upon completion, thereby enhancing the company’s financial profile and strategic positioning.&nbsp;The firm said the deal is projected to transform Intuitive Machines into a "a next-generation space prime with direct exposure to multi-billion-dollar space programs.”<h2 class="st-heading-2">What Are Stocktwits Users Saying?&nbsp;</h2><a href="https://stocktwits.com/symbol/LUNR">Intuitive Machines’ stock</a> traded over 5% higher on Monday mid-morning. On Stocktwits, retail sentiment around the stock remained in ‘bullish’ territory while message volume shifted to ‘high’ from ‘extremely high’ levels in 24 hours.&nbsp;<figure class="image"><img style="aspect-ratio:933/103;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_29_114113_png_5de79485fc.webp" alt="LUNR’s Sentiment Meter and Message Volume as of 11:30 a.m. ET on Dec. 29, 2025 | Source: Stocktwits" width="933" height="103"><figcaption>LUNR’s Sentiment Meter and Message Volume as of 11:30 a.m. ET on Dec. 29, 2025 | Source: Stocktwits</figcaption></figure>A bullish Stocktwits user said they have added to their position.&nbsp;<stembedurl>https://stocktwits.com/Kenshin1111/message/640318918</stembedurl>Another user expressed optimism about the company’s growth prospects.&nbsp;<stembedurl>https://stocktwits.com/Perseveranceforever/message/640315769</stembedurl><h2 class="st-heading-2">Government’s Boost For Space Tech&nbsp;</h2>The company has also received a boost from the Trump administration’s recent&nbsp;space policy, which launched an ambitious blueprint to reinforce America’s dominance in space exploration, defense, and commercial development.&nbsp;The policy sets aggressive goals for lunar missions, space security enhancements, and private sector growth. Intuitive Machines is working to lower the cost of lunar access, as highlighted by successful Moon landings in 2024 and 2025, including missions to the lunar south pole.Intuitive Machines is planning to test and refine its Moon RACER rover, a reusable crewed and autonomous vehicle developed to support NASA’s Artemis missions, at Texas A&amp;M University’s new space institute facility.&nbsp;LUNR stock has lost over 11% year-to-date.&nbsp;Also See:&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="http://tocktwits.com/news-articles/markets/equity/soft-bank-acquires-digital-bridge-for-4-billion-to-scale-ai-infrastructure/cL75v6iREx9">SoftBank Acquires DigitalBridge For $4 Billion To Scale AI Infrastructure</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Intuitive Machines IM-1 Lunar Lander, Nova-C, is on display before it is shipped to Cape Canaveral, Florida.

LUNR Stock Gets A Boost From Clear Street – New Price Target Implies A Whopping 56% Upside From Current Level

Clear Street highlighted that Intuitive Machines’ planned purchase of Lanteris Space Systems, expected to close by the second quarter of 2026, is now reflected in the firm’s forecasts. 

Intuitive Machines, Inc. (NASDAQ:LUNR) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Intuitive Machines, Inc. (NASDAQ:LUNR - Get Free Report) have earned a consensus rating of "Moderate Buy" from the fifteen research firms that are covering the stock, MarketBeat Ratings...

Intuitive Machines (NASDAQ:LUNR) Stock Price Down 7.2% - Here's What Happened

Intuitive Machines (NASDAQ:LUNR) Stock Price Down 7.2% - Time to Sell...

To The Moon? This Space Stock Is Experiencing A Major Momentum Shift

Intuitive Machines, Inc. (NASDAQ:LUNR) experienced a notable surge in momentum score, jumping from 27.20 on Dec. 15 to 87.00 this week.read more...

In this photo illustration the AST SpaceMobile logo is seen on a smartphone and a pc screen. 

This Space Stock More Than Quadrupled This Year - And No, It’s Not Rocket Lab Or Intuitive Machines

AST SpaceMobile’s shares have built on the momentum of its Bluebird launches as well as several deals with the likes of Verizon and the U.S. government.

Why Intuitive Machines Stock Slipped on Tuesday

Key PointsProfit-taking quashed a mini-rally for space stocks...

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.06	--	--	N/A
Q3 '25	-$0.06	-$0.06	-6.93%	MISSED
Q2 '25	-$0.01	--	--	N/A
Q1 '25	-$0.08	-$0.09	-5.55%	MISSED
Q4 '24	-$0.08	-$0.07	6.48%	BEAT

LUNR
Intuitive Machines Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest LUNR News

LUNRIntuitive Machines Inc